Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis

INTRODUCTION: AFFIRM-AHF and IRONMAN demonstrated lower rates of the combined endpoint recurrent heart failure (HF) hospitalizations and cardiovascular death (CVD) using intravenous (IV) ferric carboxymaltose (FCM) and ferric derisomaltose (FDI), respectively in patients with HF and iron deficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukadinović, Davor, Abdin, Amr, Emrich, Insa, Schulze, P. Christian, von Haehling, Stephan, Böhm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116902/
https://www.ncbi.nlm.nih.gov/pubmed/37074386
http://dx.doi.org/10.1007/s00392-023-02207-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116902/
https://www.ncbi.nlm.nih.gov/pubmed/37074386
http://dx.doi.org/10.1007/s00392-023-02207-2

Ejemplares similares